Washington Trust Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Washington Trust Bank’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,028	Closed	-$56K	–	870
2017 Q4	$56K	Hold	1,028	–	–	0.01%	412
2017 Q3	$59K	Buy	1,028 +460	+81%	+$26.9K	0.01%	385
2017 Q2	$34K	Buy	+568	New	+$32.3K	0.01%	424

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Washington Trust Bank's BIVV Position: Q1 2018 in Review

Washington Trust Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,028 shares — an estimated $56K sold.

Washington Trust Bank first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $59K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Washington Trust Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Washington Trust Bank sold 1,028 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $56K.
Washington Trust Bank first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Washington Trust Bank's Bioverativ Inc. Common Stock position peaked at $59K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Washington Trust Bank's 13F filing for Q1 2018, filed 3 Apr 2018.